Calidi Biotherapeutics, Inc.
CLDI
$0.415
-$0.016-3.71%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 405.59% | 126.91% | -26.86% | -41.35% | -80.79% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 396.30% | -73.13% | -26.78% | -75.64% | 56.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -53.70% | 4.85% | -15.57% | 144.00% | 0.00% |
| Total Current Assets | 360.47% | 36.68% | -16.06% | -55.01% | -63.18% |
|
|
|||||
| Total Current Assets | 360.47% | 36.68% | -16.06% | -55.01% | -63.18% |
| Net Property, Plant & Equipment | -9.86% | -7.86% | -7.74% | -7.11% | -2.18% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -29.95% | -4.41% | -55.14% | 35.66% | -74.06% |
| Total Assets | 113.04% | 3.51% | -13.15% | -26.09% | -46.10% |
|
|
|||||
| Total Accounts Payable | -41.97% | -21.40% | 16.62% | 35.52% | 92.96% |
| Total Accrued Expenses | -16.94% | -13.39% | -25.71% | 2.52% | 13.62% |
| Short-term Debt | 3.27% | 3.38% | -41.58% | 43.67% | -72.20% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.82% | 3.73% | -19.48% | 231.78% | -44.20% |
| Total Finance Division Other Current Liabilities | -- | -50.00% | 100.00% | -- | -- |
| Total Other Current Liabilities | -- | -50.00% | 100.00% | -- | -- |
| Total Current Liabilities | -17.99% | -11.29% | -12.71% | 46.14% | -5.90% |
|
|
|||||
| Total Current Liabilities | -17.99% | -11.29% | -12.71% | 46.14% | -5.90% |
| Long-Term Debt | -74.72% | 23.27% | -42.96% | 63.83% | 5.42% |
| Short-term Debt | 3.27% | 3.38% | -41.58% | 43.67% | -72.20% |
| Capital Leases | -14.48% | -11.89% | -10.57% | -9.22% | -4.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -27.27% | -68.85% | -18.94% | -74.27% | -21.68% |
| Total Liabilities | -25.77% | -9.50% | -17.27% | 20.40% | -7.25% |
|
|
|||||
| Common Stock & APIC | 14.77% | 6.52% | 9.35% | 0.91% | 1.25% |
| Retained Earnings | -3.48% | -4.49% | -5.40% | -7.26% | -9.01% |
| Treasury Stock & Other | 62.16% | -174.07% | -345.45% | 123.40% | -1,075.00% |
| Total Common Equity | 114.92% | 12.50% | 19.36% | -76.96% | -652.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 114.92% | 12.50% | 19.36% | -76.96% | -652.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -10.52% | -- | -- | -- | -- |
| Total Equity | 120.09% | 16.63% | 19.36% | -76.96% | -652.74% |
|
|
|||||